Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.43 |
| ▸ | CAMK2A | Q9UQM7 | 2/20 | 0.42 |
| ▸ | SRC | P12931 | 2/20 | 0.39 |
| ▸ | CXCL8 | P10145 | 3/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | FABP4 | P15090 | 1/20 | 0.35 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.35 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19248494 | 0.84 | FFAR4 (0.46) | AKR1B1 | |
| SCHEMBL19248492 | 0.83 | MEN1 (0.47) | AKR1B1ALDH1A1FABP4FABP5 | |
| SCHEMBL19248491 | 0.82 | HMGB1 (0.41) | SRCKDM4EALDH1A1HPGDHSD17B10 | |
| SCHEMBL29732929 | 0.82 | TDP1 (0.69) | TDP1AKR1B1CAMK2ACXCL8KDM4E | |
| SCHEMBL69027 | 0.82 | TDP1 (0.69) | TDP1AKR1B1CAMK2ACXCL8KDM4E | |
| SCHEMBL11306437 | 0.78 | NPC1 (0.40) | TDP1AKR1B1SRCSLC1A3SLC1A2 | |
| SCHEMBL21585561 | 0.76 | TDP1 (0.62) | TDP1AKR1B1CAMK2ACXCL8KDM4E | |
| SCHEMBL2650202 | 0.76 | TDP1 (0.53) | TDP1AKR1B1CAMK2ASRCCXCL8 | |
| Phenylacetic Acid SCHEMBL30136468 | 0.74 | AKR1B1 (0.63) | AKR1B1CAMK2AALDH1A1GAA | |
| SCHEMBL69234 | 0.73 | TDP1 (0.76) | TDP1AKR1B1CXCL8KDM4EGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2018-04-05 | — | — | US | disclosed |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | NDSU RESEARCH FOUNDATION (US) | 2017-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180093939-A9 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | TDP1 2448/4885AKR1B1 1678/4885CAMK2A 2403/4885 |
| US-20170233325-A1 | NOVEL MONOMERS FROM BIOMASS | DCXR, MANBA, PGLS | TDP1 2448/4885AKR1B1 1678/4885CAMK2A 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.